Clinical Trial Update: Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a pilot study of haploidentical donor-derived adenovirus-specific T-lymphocytes to treat refractory adenovirus infections, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection

Drugs mentioned

• Adenovirus-specific T-lymphocytes (haploidentical donor)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Adenovirus Infection | Phase 1, Phase 2 | Status: RECRUITING